Clinical collaboration Leverage MedTrace’s focus on perfusion imaging and collaboration with leading institutions (e.g., Mayo Clinic collaborations cited) to position aQuant software and 15O-water workflow optimization as a value driver for advanced imaging centers seeking cutting-edge myocardial blood flow quantification.

Regulatory readiness Target markets and customers with existing compliance frameworks (ISO 13485) and national approvals in member states, and frame the sales pitch around readiness for regulatory alignment and clear pathways to broader market clearance for non-invasive perfusion quantification tools.

Onsite cyclotron synergy Position the solution as an integrated, near-scanner workflow by connecting an onsite cyclotron with PET imaging, appealing to facilities investing in turnkey perfusion quantification for faster diagnostic decisions and improved patient throughput.

Clinical adoption timing Capitalize on the upcoming or ongoing Phase 3 evaluation of 15O-water in the US and European regulatory landscape to align pilot programs with investigational use opportunities and early adopter sites seeking differentiating capabilities in blood flow quantification.

Imaging software value Highlight aQuant and related software packages for myocardial blood flow and perfusion analysis as a cost-effective software add-on that can enhance existing PET workflows, reduce diagnostic uncertainty, and support monetizable improvements in imaging center efficiency.